Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm

Inimmune, a Missoula-based biotech company founded by nationally recognized vaccine scientists that has been working on a vaccine for COVID-19, announced today that it has raised $22 million in Series A funding led by Two Bear Capital, a venture-capital firm founded by Whitefish philanthropist Mike Goguen. The firm plans to use the Series A investment […]

For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set

In July 2020, Missoula-based biotech therapeutics company Inimmune Corporation announced the largest Series A investment in Montana history: a $22 million round led by Two Bear Capital out of Whitefish. Founded in 2016, Inimmune develops vaccines and immunotherapeutics in allergy, autoimmunity, infectious disease, opioid addiction and cancer with multiple candidates rapidly advancing to Phase I human clinical trials in […]

UM Receives Largest Single Research Award in its History

MISSOULA – The National Institutes of Health has awarded the University of Montana a five-year, $33.4 million award for the development and clinical trials of opioid vaccines. It is the largest such award in University history. The award was funded through the NIH HEAL Initiative, a national effort to speed scientific solutions to the national opioid […]

Science Behind the Silent Killer

To passing eyes, the town of Puyallup where Tomi Cook spent her high school years looks the perfect picture of Seattle suburbia. Quiet cookie-cutter houses, rows of shopping centers, happy upper-middle-class families going about their happy lives. She doubts anyone would have suspected that pills were tearing through her community. For Cook it started with […]